======= SH3KBP1 =======
== Gene Information ==
* **Official Symbol**: SH3KBP1
* **Official Name**: SH3 domain containing kinase binding protein 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30011|30011]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96B97|Q96B97]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SH3KBP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SH3KBP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300374|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes an adapter protein that contains one or more N-terminal Src homology domains, a proline rich region and a C-terminal coiled-coil domain. The encoded protein facilitates protein-protein interactions and has been implicated in numerous cellular processes including apoptosis, cytoskeletal rearrangement, cell adhesion and in the regulation of clathrin-dependent endocytosis. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017].
* **UniProt Summary**: Adapter protein involved in regulating diverse signal transduction pathways. Involved in the regulation of endocytosis and lysosomal degradation of ligand-induced receptor tyrosine kinases, including EGFR and MET/hepatocyte growth factor receptor, through a association with CBL and endophilins. The association with CBL, and thus the receptor internalization, may inhibited by an interaction with PDCD6IP and/or SPRY2. Involved in regulation of ligand-dependent endocytosis of the IgE receptor. Attenuates phosphatidylinositol 3-kinase activity by interaction with its regulatory subunit (By similarity). May be involved in regulation of cell adhesion; promotes the interaction between TTK2B and PDCD6IP. May be involved in the regulation of cellular stress response via the MAPK pathways through its interaction with MAP3K4. Is involved in modulation of tumor necrosis factor mediated apoptosis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. {ECO:0000250, ECO:0000269|PubMed:11894095, ECO:0000269|PubMed:11894096, ECO:0000269|PubMed:12177062, ECO:0000269|PubMed:12734385, ECO:0000269|PubMed:12771190, ECO:0000269|PubMed:15090612, ECO:0000269|PubMed:15707590, ECO:0000269|PubMed:16177060, ECO:0000269|PubMed:16256071, ECO:0000269|PubMed:21834987}.
|SH3 2|
|SH3 1|
|negative regulation of epidermal growth factor receptor signaling pathway|
|negative regulation of ERBB signaling pathway|
|endocytic vesicle|
|regulation of epidermal growth factor receptor signaling pathway|
|regulation of ERBB signaling pathway|
|SH3 domain binding|
|cytoplasmic vesicle membrane|
|regulation of cell shape|
|cell-cell junction|
|actin filament organization|
|axon guidance|
|neuron projection guidance|
|synapse|
|neuron projection|
|cytoskeleton|
|axonogenesis|
|axon development|
|focal adhesion|
|cell morphogenesis involved in neuron differentiation|
|supramolecular fiber organization|
|neuron projection morphogenesis|
|plasma membrane bounded cell projection morphogenesis|
|regulation of cell morphogenesis|
|cell projection morphogenesis|
|actin cytoskeleton organization|
|cell part morphogenesis|
|chemotaxis|
|taxis|
|endocytosis|
|cell morphogenesis involved in differentiation|
|actin filament-based process|
|neuron projection development|
|import into cell|
|cell morphogenesis|
|neuron development|
|cellular component morphogenesis|
|membrane organization|
|apoptotic process|
|cell migration|
|neuron differentiation|
|programmed cell death|
|regulation of anatomical structure morphogenesis|
|localization of cell|
|cell motility|
|cell death|
|cytoskeleton organization|
|cell-cell signaling|
|plasma membrane bounded cell projection organization|
|cell projection organization|
|negative regulation of signal transduction|
|locomotion|
|negative regulation of cell communication|
|negative regulation of signaling|
|generation of neurons|
|movement of cell or subcellular component|
|negative regulation of response to stimulus|
|neurogenesis|
|cell development|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp465|Cannabidiol 13μM R08 exp465]]|-2.46|
|[[:results:exp505|ML-792 0.2μM R08 exp505]]|-2.36|
|[[:results:exp343|Centrinone 0.5μM R07 exp343]]|-2.11|
|[[:results:exp100|NFN1 1μM R03 exp100]]|-1.79|
|[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|1.82|
|[[:results:exp112|S-DABN 8μM R03 exp112]]|2.53|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/694
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/26|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/16|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8105
* **Expression level (log2 read counts)**: 6.04
{{:chemogenomics:nalm6 dist.png?nolink |}}